Zomedica grants 250,000 stock options to counsel
Zomedica Corp. granted its General Counsel, Karen DeHaan‑Fullerton, 250,000 options to buy common stock at an exercise price of $0.09 per share, expiring on August 4, 2036.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Zomedica Corp. granted its General Counsel, Karen DeHaan‑Fullerton, 250,000 options to buy common stock at an exercise price of $0.09 per share, expiring on August 4, 2036. One quarter vests on the first anniversary of grant, then 1/48 vests monthly until fully vested by August 4, 2030, leaving 250,000 options held directly after the grant.
Insider Trade Summary
Grant/Award: 250,000 shares
Grant/Award
1 txn
Insider
DeHaan-Fullerton Karen
Role
General Counsel
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Options to buy Common Stock F1 | 250,000 | $0.00 | $0.00 |
Holdings After Transaction:
Options to buy Common Stock — 250,000 contracts (Direct)
Holdings Before and After:
Options to buy Common Stock, 0 to 250,000 contracts (Direct)
Footnotes (1)
- F1. one quarter (1/4) of the options to vest on the first anniversary of the date of grant and 1/48 to vest monthly thereafter until fully vested on 8/4/2030
Key Figures
Options granted: 250,000 options
Exercise price: $0.09 per share
Options held after grant: 250,000 options
+4 more
7 metrics
Options granted
250,000 options
Options to buy common stock granted to General Counsel on August 5, 2026
Exercise price
$0.09 per share
Conversion or exercise price for the 250,000 options
Options held after grant
250,000 options
Total derivative securities beneficially owned following the reported transaction
Expiration date
August 4, 2036
Expiration date of the options to buy common stock
Full vesting date
August 4, 2030
Date by which all options are scheduled to be fully vested
Initial vesting portion
1/4 of options
One quarter vests on the first anniversary of the grant date
Ongoing vesting rate
1/48 monthly
Remaining options vest monthly after the first anniversary until fully vested
Key Terms
Grant, award, or other acquisition, exercise price, vesting, underlying security
4 terms
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
exercise price financial
"conversion_or_exercise_price of $0.0900 is the exercise price per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"one quarter of the options to vest on the first anniversary and 1/48 monthly thereafter"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
underlying security financial
"underlying_security_title identifies the common stock as the underlying security"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ZOMDF report for Karen DeHaan‑Fullerton?
Zomedica Corp. reported granting General Counsel Karen DeHaan‑Fullerton 250,000 options to buy common stock at an exercise price of $0.09 per share. The award was made on August 5, 2026 and represents a new equity incentive position held directly.
What is the exercise price and term of the new ZOMDF stock options?
The granted options have an exercise price of $0.09 per share and expire on August 4, 2036. This gives the insider a 10‑year window from the grant date to exercise the options for Zomedica Corp. common shares, subject to vesting.
How do the ZOMDF options granted to the General Counsel vest over time?
One quarter of the 250,000 options vests on the first anniversary of the grant date, with the remaining 1/48 vesting monthly thereafter. The options become fully vested by August 4, 2030, creating a structured, multi‑year equity incentive for the executive.
How many ZOMDF derivative securities does the insider hold after this transaction?
Following the reported grant, Karen DeHaan‑Fullerton holds 250,000 options to buy Zomedica Corp. common stock directly. These options are currently unexercised derivative securities with an exercise price of $0.09 per share and an expiration date of August 4, 2036.
What type of security was granted in the latest ZOMDF insider filing?
The insider received Options to buy Common Stock, a derivative security giving the right to purchase Zomedica Corp. shares. The options cover 250,000 underlying shares of common stock, subject to the stated vesting schedule, exercise price, and 2036 expiration.
AI-generated analysis. How Rhea-AI works. Not financial advice.
